Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 26062391 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | sarcoidosis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis, followed by scleritis, vogt-koyanagi-harada disease, herpetic iridocyclitis without acute retinal necrosis, acute anterior uveitis associated with human leukocyte antigen (hla) -b27 and behcet's disease. | |||||||
| 26062391 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | disease her | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis, followed by scleritis, vogt-koyanagi-harada disease, herpetic iridocyclitis without acute retinal necrosis, acute anterior uveitis associated with human leukocyte antigen (hla) -b27 and behcet's disease. | |||||||
| 26062391 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | retinal necrosis, acute | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis, followed by scleritis, vogt-koyanagi-harada disease, herpetic iridocyclitis without acute retinal necrosis, acute anterior uveitis associated with human leukocyte antigen (hla) -b27 and behcet's disease. | |||||||
| 30829019 | HLA-B*27 | iridocyclitis | NA | NA | NA | unclassified | |
| hla-b27-associated uveitis is characterized by acute, recurring sudden-onset iridocyclitis with a moderate to severe amount of fibrin and cells in the anterior chamber, and is easily treatable. | |||||||
| 30829019 | HLA-B*27 | uveitis | NA | NA | NA | unclassified | |
| hla-b27-associated uveitis is characterized by acute, recurring sudden-onset iridocyclitis with a moderate to severe amount of fibrin and cells in the anterior chamber, and is easily treatable. | |||||||
| 30829019 | HLA-B*27 | uveitis | NA | NA | NA | unclassified | |
| etiological and clinical characteristics of hla-b27-associated uveitis in a tertiary referral center objectivesto investigate the demographic, etiologic, and clinical features of hla-b27-associated uveitis.materials and methodsthe clinical records of 91 patients diagnosed with hla-b27-associated uveitis at the ulucanlar eye training and research hospital between the years of 2005 and 2016 were reviewed. | |||||||
| 30829019 | HLA-B*27 | uveitis | NA | NA | NA | unclassified | |
| the most common complications were cataract (n=12, 6.7%) and ocular hypertension (n=15, 8.3%).conclusionninety-one (6.3%) of the 1422 patients followed in our uvea clinic were diagnosed with hla-b27-associated uveitis. | |||||||
| 30829019 | HLA-B*27 | ocular hypertension | NA | NA | NA | unclassified | |
| the most common complications were cataract (n=12, 6.7%) and ocular hypertension (n=15, 8.3%).conclusionninety-one (6.3%) of the 1422 patients followed in our uvea clinic were diagnosed with hla-b27-associated uveitis. | |||||||
| 30829019 | HLA-B*27 | cataract | NA | NA | NA | unclassified | |
| the most common complications were cataract (n=12, 6.7%) and ocular hypertension (n=15, 8.3%).conclusionninety-one (6.3%) of the 1422 patients followed in our uvea clinic were diagnosed with hla-b27-associated uveitis. | |||||||
| 31009267 | HLA-B*27 | iridocyclitis | NA | NA | NA | unclassified | |
| the three most common causes were behcet's disease, hla-b27-associated uveitis, and herpetic iridocyclitis. | |||||||
Copyright 2024